Clene Inc. secures additional NIH grant funds for ALS therapy

Go back to Clene Inc. secures additional NIH grant funds for ALS therapy
(NASDAQ: CLNN) Delayed: 3.62 -0.23 (5.97%)
Previous Close $3.85    52 Week High
Open $3.82    52 Week Low
Day High $3.82    P/E N/A 
Day Low $3.60    EPS
Volume 252,034